Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- WellWithAllWellWithAll Announces Judges for $1 Million Prize Competition to Accelerate Breakthrough AI-Powered Health SolutionsThe competition has uncovered AI health breakthroughs with the power to reach nearly 6 million Americans the health system has overlooked. A world-class panel will decide which ones win a share of the $1 million purse, with support to scale from M&T Bank, AARP, The Boston Foundation and...
- National Certification CorporationNCC's CEO Robin Bissinger, PhD, APRN, NNP-BC, FAAN is a contributor to a recent articleThe National Certification Corporation (NCC) is pleased to announce the availability of the recent article, "Nurse practitioner program director survey: Direct patient care clinical hours and DNP degree". Published in the Journal of Nursing...
- AbbVieSkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare OfferingsCompanies: AbbVieIn clinical testing, Barrier Calming Cream improved skin barrier support and reduced skin dryness by 30% after just two weeks1 SkinMedica® also introduces HA5® Hydra Collagen Facial Mist for easy, on-the-go hydration IRVINE, Calif., Sept. 1, 2026 -- Allergan Aesthetics, an...
- VivoSim Labs to Add Rat Liver Model to NAMkind PlatformNew cross-species capability is designed to help pharma distinguish rat-specific liver toxicity from risks that may translate to humans
- Guardant Health, Inc.Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer ScreeningPALO ALTO, Calif., September 01, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) will be covered in Carelon Healthcare Services clinical guidelines effective November 15. Carelon Healthcare Services is one of the largest specialty benefits managers in the country and subsidiary of one of the largest health insurance companies in the U.S spanning more than 14 states.
- MiraLandmark 2026 Clinical Study Validates At-Home Quantitative Multi-Hormone Monitoring Against Ultrasound Gold StandardA peer-reviewed study published in Reproductive BioMedicine Online demonstrates 96% agreement between Mira at-home LH measurements and transvaginal ultrasound, marking a major milestone in decentralized reproductive care. SAN FRANCISCO, Sept. 1, 2026 -- A landmark clinical...
- OpenAIHealthcare organizations can now connect EHR and additional industry data to ChatGPTCompanies: OpenAIChatGPT can now connect to trusted healthcare data, helping clinicians securely access patient context, medical research, and more.
- Belite Bio, IncBelite Bio to Participate in Four Upcoming Investor ConferencesBelite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:
- Relmada TherapeuticsRelmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare ConferenceRelmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that senior management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference being held in Boston, MA, from September 8 - 10, 2026.
- Septerna, Inc.Septerna to Participate in Upcoming Investor ConferencesSepterna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following investor conferences in September:
- DocGo Inc.DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare ConferenceNEW YORK, September 01, 2026--DocGo Inc. (Nasdaq: DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday September 16th, and will deliver a fireside presentation at 12:20 PM ET on that day. A webcast of the event will be available on the investor relations section of DocGo’s
- Faeth TherapeuticsFaeth Therapeutics to Participate in Upcoming September Investor ConferencesAUSTIN, Texas, September 01, 2026--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that management will participate in the following upcoming investor conferences: